Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Ear, Nose, & Throat Journal|March 28, 2022
Tracheobronchial chondritis as an immune-related adverse event occurring during the administration of nivolumab for recurrent hypopharyngeal squamous cell carcinomaMiwako Someya, Takahito Kondo, Akira Okimura, et al.
Experimental and Molecular Pathology|October 13, 2009
Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cellsYoshihiko Hirohashi, Toshihiko Torigoe, Itaru Hirai, et al.
Cancer Science|October 31, 2018
Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cellsKazue Watanabe, Tomohide Tsukahara, Shingo Toji, et al.
Scientific Reports|March 21, 2018
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84GlyMark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa, et al.
Journal of Autoimmunity|January 11, 2016
CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptorsKenji Chamoto, Tingxi Guo, Osamu Imataki, et al.
Ear, Nose, & Throat Journal|July 20, 2021
Laryngeal Cancer With Lung Metastases Showing Long-Term Complete Response and Delayed Immune-Related Adverse Event After Nivolumab DiscontinuationTakahito Kondo, Munehide Nakatsugawa, Mitsuru Okubo, et al.
Cancer Science|October 25, 2023
Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factorShuto Hamada, Tomohide Tsukahara, Yuto Watanabe, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2012
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapyDaisuke Nobuoka, Toshiaki Yoshikawa, Mari Takahashi, et al.
Cancer Immunology Research|August 26, 2021
CD8+ T-cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1Yasuhiro Kikuchi, Serina Tokita, Tomomi Hirama, et al.
International Journal of Oncology|June 21, 2011
Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, LengsinMunehide Nakatsugawa, Kazutaka Horie, Toshiaki Yoshikawa, et al.
Pageof 9